Abstract 126: Extreme Selection Constrains Ability of EGFR-driven Lung Adenocarcinoma to Diversify in Response to Erlotinib Therapy
CANCER RESEARCH（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined